- Wang, Chia-Ching;
- Thanh, Cassandra;
- Gibson, Erica A;
- Ball-Burack, Maya;
- Hogan, Louise E;
- Descours, Benjamin;
- Jones, Norman;
- Carvidi, Alexander B;
- Munter, Sadie;
- Bakkour, Sonia;
- Busch, Michael P;
- Milush, Jeffrey M;
- Deeks, Steven G;
- Henrich, Timothy J
Anti-CD30 therapy for Hodgkin lymphoma led to transient loss of detectable CD4+ T-cell HIV RNA and a decrease in residual plasma viremia. Targeting nonviral markers expressed on HIV-1 transcriptionally active cells may lead to reduced measures of HIV-1 persistence.
